Is a Synthetic Peptide the Same Molecule as the Natural One?

A synthetic peptide with the same sequence as one the body makes is usually described as identical to it. At the level of the written sequence that is true. At the level of what is actually in the vial, several differences persist, and they are the reason the distinction gets made at all.

The sequence is the easy part

Solid-phase synthesis builds a chain one residue at a time from protected amino acids. If every coupling and deprotection goes to completion, the product has exactly the sequence intended, and a correct mass confirms the elemental composition.

So for a short, unmodified sequence, the synthetic material genuinely is the same molecule. The differences that follow are about what accompanies it and what has been left out.

What the body adds that a synthesiser does not

Peptides produced biologically are made by ribosomes and then processed. Along the way they can acquire modifications that a synthesis will not reproduce unless someone deliberately builds them in:

• Terminal processing. Amidation of the C-terminus is enzymatic in nature and must be specified in a synthesis. Pyroglutamate formation at the N-terminus can be either.
• Glycosylation. Sugar chains attached at specific residues, absent from any standard synthesis.
• Phosphorylation, acetylation, hydroxylation. Site-specific and enzyme-driven.
• Disulfide arrangement. A cell folds a chain with chaperone assistance into one specific pairing. A synthetic peptide with several cysteines has to be oxidised deliberately and can fold into the wrong arrangement.

A synthetic version lacking a modification the natural one carries is a different molecule with the same sequence, and its mass will say so.

What a synthesiser adds that the body does not

The impurity profile runs the other way. Chemical synthesis produces a characteristic set of related species: deletion sequences where a coupling failed, truncations where a chain stopped growing, incompletely deprotected material carrying a leftover protecting group, and oxidation products formed during synthesis or workup.

Biological production produces a different set — misincorporations, truncations from premature termination, host-derived contaminants — and essentially none of the protecting-group chemistry.

So the two routes are distinguishable by what surrounds the main peak, even when the main peak is the same compound. This is one reason an impurity profile is informative beyond its arithmetic.

Stereochemistry

Biological synthesis uses L-amino acids exclusively, with a handful of specialised exceptions. Chemical synthesis uses whatever is loaded, which is why D-residues appear routinely in designed analogs.

It also means racemisation is a synthetic concern in a way it is not a biological one. A small proportion of a residue can invert during coupling, producing a diastereomer of identical mass. Natural material does not carry that impurity class; synthetic material can. The chemistry is covered in racemisation and chiral purity.

Isotopes

Carbon in living tissue reflects the isotopic composition of what the organism consumed. Carbon in a synthetic amino acid reflects its own manufacturing feedstock, often petrochemical.

The difference is small and does not affect chemical behaviour, but it is measurable by isotope ratio mass spectrometry, and it is the basis on which material can sometimes be assigned to a biological or synthetic origin. It is not part of routine characterisation.

Fragments are a separate question

Many compounds described as endogenous are fragments of a larger natural protein rather than molecules the body releases as such. A fragment corresponding to residues 17 to 23 of a 43-residue protein exists in nature only as part of that protein unless something cleaves it.

Calling such a fragment endogenous is a statement about where its sequence came from, not about the molecule circulating anywhere. The naming conventions that make this confusing are set out in peptide nomenclature, analogs, fragments and salts.

What follows for analysis

Identity confirmation for a synthetic peptide is a sequence and a mass. That establishes the molecule is what was intended. It does not establish equivalence to a natural counterpart where the natural one carries modifications, and it does not address stereochemistry.

Where equivalence to a natural molecule actually matters, it has to be demonstrated rather than inferred from a matching sequence — and for most laboratory work the synthetic material’s own characterisation is the relevant question, not its relationship to anything biological.